LETTER


Antimicrobial Activity of Lidocaine, Bupivacaine, Mepivacaine and Ropivacaine on Staphylococcus epidermidis, Staphylococcus aureus and Bacillus subtilis



S. Neuwersch1, *, M. Köstenberger1, S. Sorschag2, W. Ilias3, R. Likar1
1 Department of Anaesthesiology and Intensive Care, General Hospital Klagenfurt, Klagenfurt, Austria
2 Institute of Laboratory Diagnostics and Microbiology, General Hospital Klagenfurt, Klagenfurt, Austria
3 Vienna Private Clinic, Vienna, Austria


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 2346
Abstract HTML Views: 1108
PDF Downloads: 379
ePub Downloads: 245
Total Views/Downloads: 4078
Unique Statistics:

Full-Text HTML Views: 1228
Abstract HTML Views: 657
PDF Downloads: 252
ePub Downloads: 188
Total Views/Downloads: 2325



© 2017 Neuwersch et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the Department of Anaesthesiology and Intensive Care, Institution: General Hospital Klagenfurt, Klagenfurt, Austria; Tel: 0043/538/0; Email: stefan.neuwersch@kabeg.at


Abstract

Introduction:

Various studies have shown a possible antimicrobial activity of different local anaesthetics, which may affect the results of microbial assessment of biopsies. The purpose of this study was to test the antimicrobial activity of different commonly used anaesthetic agents on Staphylococcus epidermidis, Staphylococcus aureus and Bacillus subtitles to reproduce data and to compare the findings.

Methods:

Local anaesthetics tested were commercially available solutions of lidocaine (Xyloneural®, Xylanaest pur.®), bupivacaine (Bucain®), mepivacaine (Mecain®) and ropivacaine (Naropin®, Ropinaest®).2%, 1%, 0.5%, 0.25% and 0.1% (20, 10, 5, 2.5, 1 mg/ml) dilutions of these local anaesthetics were prepared with sterile 0.9% saline. Bacteria used in this study were Staphylococcus epidermidis, Staphylococcus aureus and Bacillus subtilis. 10 μl of different local anaesthetic dilution placed on thin wafers were added to Mueller Hinton Agar and cultured. After 24 hours, a zone of inhibition around the wafers was evaluated.

Results:

Local anaesthetics in different concentrations did not show any zone of inhibition on Staphylococcus epidermidis, Staphylococcus aureus or Bacillus subtilis.

Conclusion:

In summary, neither lidocaine, bupivacaine, mepivacaine nor ropivacaine showed an antibacterial effect on Staphylococcus epidermidis, Staphylococcus aureus and Bacillus subtilis.

Implications:

Due to these findings this local anaesthetics can be used in daily clinical routine to perform pain free diagnostic procedures in which culture specimens are to be obtained. Due to inconsistent results in prior studies, we recommend to use the lowest concentration possible of the local anaesthetic, also to avoid other possible side effects of local agents.

Keywords: Pain, Local anaestetic, Concentration, Antibacterial effect.